Filtrovat podle Last updated date SelectpopředFrom - To Date Datum ukončení Tento týden Tento měsíc Minulý týden Minulý měsíc Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Výsledky (3827) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank New measures to minimise risk of meningioma with medicines containing nomegestrol or chlormadinone 2 Září 2022NewsHumanPharmacovigilanceReferrals First adapted COVID-19 booster vaccines recommended for approval in the EU 1 Září 2022NewsHumanCOVID-19Vaccines Have your say on EMA’s communications – how are we doing? 1 Září 2022NewsCorporate EMA’s Emergency Task Force advises on intradermal use of Imvanex / Jynneos against monkeypox 19 Srpen 2022NewsHumanMpoxVaccines EMA starts review of conditional marketing authorisation application for Skycovion COVID-19 vaccine 18 Srpen 2022NewsHumanCOVID-19Vaccines EMA business hours over Assumption Day, 15 August 11 Srpen 2022NewsCorporateCOVID-19 Big data use for public health: publication of Big Data Steering Group workplan 2022-25 28 Červenec 2022NewsHumanResearch and development EMA reviewing data on sabizabulin for COVID-19 27 Červenec 2022NewsHumanCOVID-19Medicines EMA response to the monkeypox public health emergency 27 Červenec 2022NewsHumanMpoxMedicines Hydroxyethyl-starch solutions for infusion recommended for suspension from the market 26 Červenec 2022NewsHumanPharmacovigilance 1 … 40 41 42 43 44 Page 44 of 383 45 46 47 48 … 383
New measures to minimise risk of meningioma with medicines containing nomegestrol or chlormadinone 2 Září 2022NewsHumanPharmacovigilanceReferrals
First adapted COVID-19 booster vaccines recommended for approval in the EU 1 Září 2022NewsHumanCOVID-19Vaccines
EMA’s Emergency Task Force advises on intradermal use of Imvanex / Jynneos against monkeypox 19 Srpen 2022NewsHumanMpoxVaccines
EMA starts review of conditional marketing authorisation application for Skycovion COVID-19 vaccine 18 Srpen 2022NewsHumanCOVID-19Vaccines
Big data use for public health: publication of Big Data Steering Group workplan 2022-25 28 Červenec 2022NewsHumanResearch and development
Hydroxyethyl-starch solutions for infusion recommended for suspension from the market 26 Červenec 2022NewsHumanPharmacovigilance